Kathryn S Prickett

Title: Innovations in Immunology: The Contributions of Kathryn S. Prickett

Introduction

Kathryn S. Prickett, an accomplished inventor based in Seattle, WA, has made significant strides in the field of immunology through her research and innovations. With a total of three patents to her name, Prickett's work focuses on improving immunological responses through the development of novel conjugates and monoclonal antibodies.

Latest Patents

Prickett's latest patents include groundbreaking discoveries in immunogenic conjugates. One of her notable inventions is a conjugate immunogen comprising peptide fragments with substantial homology to the N-terminal region of Pasteurella haemolytica leukotoxins, covalently linked to suitable carrier proteins. This innovation holds potential for enhancing the efficacy of immunological treatments. Additionally, Prickett has developed a hybridoma and monoclonal antibody, specifically the calcium-dependent monoclonal antibody 4E11, derived from a murine hybridoma cell line. This antibody is invaluable for purifying a recombinant fusion protein tagged with the N-terminal identification peptide DYKDDDDK.

Career Highlights

Kathryn S. Prickett currently works at Immunex Corporation, a company renowned for its cutting-edge research in biotechnology and pharmaceuticals. Throughout her career, she has made substantial contributions to the understanding and application of immunological therapies. Her inventions have important implications in the realms of disease treatment and vaccine development, showcasing her commitment to advancing healthcare solutions.

Collaborations

Prickett's collaborative efforts include working closely with her esteemed coworker, Thomas P. Hopp. Together, they have contributed to significant advancements in immunological research, combining their expertise to foster innovation and develop technologies that can potentially improve patient outcomes.

Conclusion

Kathryn S. Prickett's innovations and inventions not only highlight her capabilities as an inventor but also reflect her dedication to the field of immunology. Through her patents and collaborative efforts at Immunex Corporation, she continues to pave the way for future developments in immunological therapies, reinforcing her status as a leading figure in scientific innovation.